ChemoCentryx

- NASDAQ:CCXI
Last Updated 2021-08-03
  • ChemoCentryx develops orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
  • Locations

    • Mountain View CA
  • Total Funding (USD)

    144.5 million
  • Industries

    Software, Mobile Apps, Drones, Cyber Security, Real Estate, Internet
  • Security

    Type: ORD
    CUSIP: 16383L106
    ISIN: US16383L1061
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.